• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (CSE:OPTI)

5.950 +0.150 (+2.59%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,409
Open 5.900
Bid (Size) 5.900 (300)
Ask (Size) 6.100 (200)
Prev. Close 5.800
Today's Range 5.690 - 6.150
52wk Range 0.1050 - 10.25
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes First Psilocybin Export to United Kingdom for Planned Phase 2 Trial
June 10, 2026
Via Investor Brand Network
Topics Supply Chain
News headline image
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
June 10, 2026
The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization from... 
From OPTIMI HEALTH CORP.
Via GlobeNewswire

Performance

YTD
+1788.9%
+1788.9%
1 Month
-22.8%
-22.8%
3 Month
+1987.7%
+1987.7%
6 Month
+1676.1%
+1676.1%
1 Year
+3400.0%
+3400.0%

More News

Read More
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Advances Ibogaine Drug Development Program
June 08, 2026
Via Investor Brand Network
News headline image
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
June 08, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes GMP Production Run of 5mg Psilocybin Drug Product
June 02, 2026
Via Investor Brand Network
News headline image
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
June 02, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update
May 29, 2026
Via Investor Brand Network
News headline image
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
May 29, 2026
From OPTIMI HEALTH CORP.
Via GlobeNewswire
PsychedelicNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Featured in Diamond Equity Research Initiation Report Highlighting Commercial Psychedelics Opportunity
May 27, 2026
Via Investor Brand Network
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting
May 21, 2026
Via Investor Brand Network
News headline image
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
May 20, 2026
Via PressReach
Topics Regulatory Compliance
PsychedelicNewsBreaks – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) Launches Ibogaine Initiative Amid U.S. Policy Shift
April 21, 2026
Via Investor Brand Network
News headline image
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
April 20, 2026
Via PressReach
News headline image
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
March 16, 2026
Via PressReach
Topics Regulatory Compliance
News headline image
Optimi Health Completes MD-MA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
February 09, 2026
Via PressReach
News headline image
Optimi Health Completes First 2026 Production of MD-MA and Psilo Capsules
January 26, 2026
Via PressReach
News headline image
Early Warning Press Release in Accordance with National Instrument 62-103
April 04, 2024
Via Newsfile
Optimi Health Announces C$3.27 Million Private Placement with Strategic Investment from Lululemon Founder Chip Wilson
October 12, 2022
Via PressReach
News headline image
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Via PressReach
News headline image
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Via PressReach
Topics Cannabis
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Via FinancialNewsMedia
Topics Cannabis
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA
September 22, 2022
Via PressReach
Topics Supply Chain
Psychedelics May Make People Less Afraid of Death
September 07, 2022
Via FinancialNewsMedia
Topics Supply Chain
Psychedelics Use Among Young Adults Reaches All-Time High
September 01, 2022
Via FinancialNewsMedia
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
Via FinancialNewsMedia
Topics Supply Chain

Frequently Asked Questions

Is Optimi Health Corp publicly traded?
Yes, Optimi Health Corp is publicly traded.
What exchange does Optimi Health Corp trade on?
Optimi Health Corp trades on the Canadian Securities Exchange
What is the ticker symbol for Optimi Health Corp?
The ticker symbol for Optimi Health Corp is OPTI on the Canadian Securities Exchange
What is the current price of Optimi Health Corp?
The current price of Optimi Health Corp is 5.950
When was Optimi Health Corp last traded?
The last trade of Optimi Health Corp was at 06/26/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap